Cardiology · Acute Decompensated Heart Failure
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Acute decompensated heart failure is the most common cause of cardiogenic pulmonary edema, typically presenting with orthopnea, paroxysmal nocturnal dyspnea, and bilateral rales on lung auscultation.
Chest X-ray findings diagnostic of pulmonary edema include cephalization of pulmonary vessels, Kerley B lines, pleural effusions, and bat-wing opacities.
B-type natriuretic peptide (BNP) levels are significantly elevated in cardiogenic pulmonary edema and help differentiate it from non-cardiogenic pulmonary edema (e.g., ARDS).
Initial management of acute pulmonary edema focuses on LMNOP: Lasix (furosemide), Morphine, Nitrates, Oxygen, and Positioning (upright).
Non-invasive positive pressure ventilation (NIPPV), such as BiPAP, is the first-line respiratory support to reduce preload and afterload while improving oxygenation.
Cardiogenic shock is a life-threatening complication of pulmonary edema characterized by hypotension, cool extremities, and end-organ hypoperfusion requiring inotropic support.
Non-cardiogenic pulmonary edema (e.g., ARDS) is distinguished by a normal pulmonary capillary wedge pressure (PCWP) (<18 mmHg) and the absence of primary cardiac dysfunction.
Vignette unlocked
A 72-year-old male with a history of hypertension and coronary artery disease presents to the emergency department with severe shortness of breath. He reports waking up gasping for air last night and has been unable to lie flat. Physical examination reveals a blood pressure of 170/95 mmHg, respiratory rate of 28/min, and oxygen saturation of 86% on room air. Auscultation demonstrates bilateral crackles extending to the mid-lung fields and an S3 gallop. A chest X-ray shows cardiomegaly and bilateral interstitial infiltrates with Kerley B lines.
What is the most appropriate initial management for this patient?
Intravenous loop diuretics and non-invasive positive pressure ventilation (NIPPV)
The patient presents with classic signs of acute cardiogenic pulmonary edema; initial management requires rapid reduction of preload and afterload using diuretics and nitrates, alongside NIPPV to improve respiratory mechanics.
Full handout
High yield triage
Etiology / Epidemiology
Driven by left-sided heart failure or fluid overload. High risk in patients with CAD, HTN, and valvular disease.
Clinical Manifestations
Presents with orthopnea, paroxysmal nocturnal dyspnea, and pink frothy sputum. Exam reveals rales and S3 gallop.
Diagnosis
Clinical diagnosis supported by CXR showing cephalization and Kerley B lines. Echocardiogram is the gold standard for etiology.
Treatment
Immediate furosemide (LMNOP: Lasix, Morphine, Nitrates, Oxygen, Position). Avoid beta-blockers in acute decompensation.
Prognosis
High mortality if untreated. 50% 5-year mortality post-HF diagnosis. Monitor BNP levels for therapeutic response.
Full handout
Epidemiology & Etiology
Primarily caused by cardiogenic factors including acute MI, hypertensive emergency, or valvular regurgitation. Non-cardiogenic causes include ARDS, sepsis, and high-altitude exposure. Incidence increases significantly with age and history of ischemic heart disease.
Pertinent Anatomy
Fluid accumulation occurs in the alveolar-capillary membrane space. Increased pulmonary capillary wedge pressure forces transudate into the alveoli, impairing gas exchange. The left atrium acts as the pressure reservoir; failure leads to retrograde pulmonary congestion.
Pathophysiology
Increased hydrostatic pressure exceeds the oncotic pressure of the pulmonary capillaries. This leads to alveolar flooding and severe ventilation-perfusion (V/Q) mismatch. The resulting hypoxemia triggers sympathetic activation, further increasing systemic vascular resistance and worsening the cardiac workload.
Clinical Manifestations
Patients exhibit dyspnea, tachypnea, and use of accessory muscles. Pink frothy sputum is a pathognomonic sign of severe alveolar edema. Physical exam reveals diffuse rales (crackles) and an S3 gallop. Severe respiratory distress and altered mental status are red flags for impending failure.
Diagnosis
The CXR is the initial diagnostic test of choice, demonstrating cardiomegaly, pleural effusions, and Kerley B lines. BNP > 400 pg/mL strongly suggests heart failure. Echocardiogram is the gold standard to assess ejection fraction and valvular function.
Treatment
Initial management includes oxygen (NIPPV/CPAP), nitroglycerin for preload reduction, and furosemide for diuresis. Avoid beta-blockers in acute decompensated heart failure as they decrease contractility. If cardiogenic shock is present, initiate inotropes like dobutamine.
Prognosis
Prognosis is tied to the underlying ejection fraction and comorbid renal function. Acute respiratory failure is the primary immediate complication. Long-term management requires strict sodium restriction and ACE inhibitor titration.
Differential Diagnosis
Pneumonia: fever and productive purulent sputum
COPD exacerbation: history of smoking and wheezing
Pulmonary embolism: sudden onset pleuritic chest pain
ARDS: non-cardiogenic, normal pulmonary capillary wedge pressure
Asthma: history of reversible airway obstruction